New to Pano? Start here

4 sources·Politics

Trump Administration Seeks to Dismiss Lawsuit Against Mifepristone Access

The Trump administration aims to dismiss a lawsuit from GOP states challenging telehealth access to mifepristone, citing lack of legal standing.

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).
Reliable
The underlying sources consistently report facts with minimal bias, demonstrating high-quality journalism and accuracy.
Balanced
The underlying sources are either a balanced mix of left and right or primarily centrist.
  1. Trump administration asks judge to toss suit restricting access to abortion medication

    Nothing is stopping the states from filing the lawsuit someplace else, attorney Daniel Schwei wrote, but the venue has to have some connection to the claims being made.

    Trump administration asks judge to toss suit restricting access to abortion medication

    Associated PressAssociated Press·9d
    Reliable
    This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
    ·
    Center
    This outlet is balanced or reflects centrist views.
  2. Trump to continue Biden's court defense of abortion drug mifepristone

    The justice department and the office of Missouri’s attorney general, Andrew Bailey, did not immediately respond to requests for comment.

    Trump to continue Biden's court defense of abortion drug mifepristone

    The GuardianThe Guardian·9d
    Reliable
    This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
    ·
    Leans Left
    This outlet slightly leans left.
  1. FOX News
  2. CBS News
  3. Associated Press
  4. The Guardian

Updated: May 5th, 2025, 10:30 PM ET

Summary

A summary of the key points of this story verified across multiple sources.

The Trump administration is asking a Texas federal judge to dismiss a lawsuit from Missouri, Idaho, and Kansas that seeks to limit access to mifepristone, a medication abortion drug. The Justice Department argues the states lack legal standing and connection to Texas, asserting that the states can pursue their claims elsewhere. This follows previous Supreme Court rulings these states failed to establish harm related to the FDA's regulations expanding mifepristone access. The legal battle highlights ongoing tensions regarding abortion access and state versus federal authority.


Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

This story is either non-partisan or does not have the required sources to create partisan perspectives.


FAQs

A list of follow-up questions readers often ask about this story.